Literature DB >> 24662659

18F-FDG hepatic superscan in a patient with chronic myeloid leukemia.

Bulin Du1, Xuena Li, Na Li, Yaming Li, Bailing Hsu.   

Abstract

A 62-year-old man with a history of breakpoint cluster region-ABL-positive chronic myeloid leukemia treated with hydroxyurea and interferon alfa for 4 years presented a lesion in the left lateral lobe of the liver. Besides an FDG-avid lesion, his 18F-FDG PET/CT study showed intense and diffuse FDG uptake (reminiscent of a hepatic superscan) throughout the rest of the left lobe and the right anterior lobe of the liver. This interesting superscan indicated that patients with chronic myeloid leukemia may show hepatic involvement by leukemia cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662659     DOI: 10.1097/RLU.0000000000000413

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  (18)F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma.

Authors:  Guangjie Yang; Pei Nie; Zhenguang Wang; Xiaoming Xing
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-03       Impact factor: 9.236

Review 2.  Clinical Pearls: Etiologies of Superscan Appearance on Fluorine-18-Fludeoxyglucose Positron Emission Tomography-Computed Tomography.

Authors:  John Joseph Manov; Patrick J Roth; Russ Kuker
Journal:  Indian J Nucl Med       Date:  2017 Oct-Dec

3.  Diffuse Skeletal Uptake on 18F-Fluoro-2-Deoxy-d-glucose Positron Emission Tomography/Computed Tomography Scan in a Patient with Acute Lymphoblastic Leukemia: A Typical Superscan Pattern Resembling NaF Positron Emission Tomography Scan.

Authors:  Abbas Yousefi-Koma; Yaser Shiravand; Mohsen Qutbi
Journal:  Indian J Nucl Med       Date:  2019 Oct-Dec

4.  Detection of Diffuse Infiltrative Primary Hepatic Lymphoma on FDG PET-CT: Hallmarks of Hepatic Superscan.

Authors:  Sonia Mahajan; Shefali Kalra; Madhavi Chawla; Pankaj Dougall
Journal:  World J Nucl Med       Date:  2016 May-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.